Article No
AG-CN2-0335-M050
Specifications
| CAS No | 38601-77-3 |
| MW | 806.9 |
| Article No | AG-CN2-0335-M050 |
| Country Availability | SE, FI, DK, NO, IS, EE, LV, LT |
| Description | Rifamycin PR-3 |
| Supplier | Adipogen Life Sciences |
| Format | Powder |
| Notes | Ansamycin antibiotic. Selective inhibitor of bacterial DNA-dependent RNA polymerase (RNAP). Effective against mycobacteria and therefore used in research of tuberculosis, leprosy and Mycobacterium avium complex (MAC) infections.|Chemical. CAS: 21288-98-2. Formula: C43H54N2O13. MW: 806.9. Semisynthetic. Ansamycin antibiotic. Selective inhibitor of bacterial DNA-dependent RNA polymerase (RNAP). Effective against mycobacteria, and are therefore used in research of tuberculosis, leprosy and mycobacterium avium complex (MAC) infections. |
| Molecular Formula | C43H54N2O13 |
| Alias Names | 3'-(Methoxycarbonyl)-1',2'-dimethyl-Rifamycin II; NCI 143-458; NCI 143458 |
| Product Type | Antibiotics & Culture Media |
| Purity | >94% |
| Shipping Information | RT |
| Size | 50 mg |
| Solubility | Soluble in DMSO, aqueous acetonitrile or ethanol. |
| Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Storage | -20°C, 4°C |
| Technical Specifications | Chemical. CAS: 21288-98-2. Formula: C43H54N2O13. MW: 806.9. Semisynthetic. Ansamycin antibiotic. Selective inhibitor of bacterial DNA-dependent RNA polymerase (RNAP). Effective against mycobacteria, and are therefore used in research of tuberculosis, leprosy and mycobacterium avium complex (MAC) infections. |
| Product Page Updated | 2024-02-01T08:25:01.492Z |
